184 related articles for article (PubMed ID: 8934227)
1. Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts.
Déglon N; Heyd B; Tan SA; Joseph JM; Zurn AD; Aebischer P
Hum Gene Ther; 1996 Nov; 7(17):2135-46. PubMed ID: 8934227
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF.
Aebischer P; Pochon NA; Heyd B; Deglon N; Joseph JM; Zurn AD; Baetge EE; Hammang JP; Goddard M; Lysaght M; Kaplan F; Kato AC; Schluep M; Hirt L; Regli F; Porchet F; De Tribolet N
Hum Gene Ther; 1996 May; 7(7):851-60. PubMed ID: 8860837
[TBL] [Abstract][Full Text] [Related]
3. Rescue of motoneurons from axotomy-induced cell death by polymer encapsulated cells genetically engineered to release CNTF.
Tan SA; Déglon N; Zurn AD; Baetge EE; Bamber B; Kato AC; Aebischer P
Cell Transplant; 1996; 5(5):577-87. PubMed ID: 8889216
[TBL] [Abstract][Full Text] [Related]
4. Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease.
Emerich DF; Cain CK; Greco C; Saydoff JA; Hu ZY; Liu H; Lindner MD
Cell Transplant; 1997; 6(3):249-66. PubMed ID: 9171158
[TBL] [Abstract][Full Text] [Related]
5. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts.
Régulier E; Schneider BL; Déglon N; Beuzard Y; Aebischer P
Gene Ther; 1998 Aug; 5(8):1014-22. PubMed ID: 10326023
[TBL] [Abstract][Full Text] [Related]
6. Astrocytes infected with replication-defective adenovirus containing a secreted form of CNTF or NT3 show enhanced support of neuronal populations in vitro.
Smith GM; Hale J; Pasnikowski EM; Lindsay RM; Wong V; Rudge JS
Exp Neurol; 1996 May; 139(1):156-66. PubMed ID: 8635562
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease.
Régulier E; Pereira de Almeida L; Sommer B; Aebischer P; Déglon N
Hum Gene Ther; 2002 Nov; 13(16):1981-90. PubMed ID: 12427308
[TBL] [Abstract][Full Text] [Related]
8. Tumor cells expressing the herpes simplex virus-thymidine kinase gene in the treatment of Walker 256 meningeal neoplasia in rats.
Vrionis FD; Wu JK; Qi P; Cano WG; Cherington V
J Neurosurg; 1996 Feb; 84(2):250-7. PubMed ID: 8592228
[TBL] [Abstract][Full Text] [Related]
9. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
[TBL] [Abstract][Full Text] [Related]
10. Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease.
Emerich DF; Lindner MD; Winn SR; Chen EY; Frydel BR; Kordower JH
J Neurosci; 1996 Aug; 16(16):5168-81. PubMed ID: 8756445
[TBL] [Abstract][Full Text] [Related]
11. Encapsulation matrices for neurotrophic factor-secreting myoblast cells.
Li RH; Williams S; Burkstrand M; Roos E
Tissue Eng; 2000 Apr; 6(2):151-63. PubMed ID: 10941210
[TBL] [Abstract][Full Text] [Related]
12. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir.
Rosenfeld ME; Feng M; Michael SI; Siegal GP; Alvarez RD; Curiel DT
Clin Cancer Res; 1995 Dec; 1(12):1571-80. PubMed ID: 9815958
[TBL] [Abstract][Full Text] [Related]
13. Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuronopathy in the mouse.
Sagot Y; Tan SA; Baetge E; Schmalbruch H; Kato AC; Aebischer P
Eur J Neurosci; 1995 Jun; 7(6):1313-22. PubMed ID: 7582105
[TBL] [Abstract][Full Text] [Related]
14. Herpes vector-mediated delivery of marker genes to disseminated central nervous system tumors.
Kramm CM; Rainov NG; Sena-Esteves M; Chase M; Pechan PA; Chiocca EA; Breakefield XO
Hum Gene Ther; 1996 Feb; 7(3):291-300. PubMed ID: 8835217
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients.
Aebischer P; Schluep M; Déglon N; Joseph JM; Hirt L; Heyd B; Goddard M; Hammang JP; Zurn AD; Kato AC; Regli F; Baetge EE
Nat Med; 1996 Jun; 2(6):696-9. PubMed ID: 8640564
[TBL] [Abstract][Full Text] [Related]
16. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.
Eck SL; Alavi JB; Alavi A; Davis A; Hackney D; Judy K; Mollman J; Phillips PC; Wheeldon EB; Wilson JM
Hum Gene Ther; 1996 Aug; 7(12):1465-82. PubMed ID: 8844206
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models.
Eastham JA; Chen SH; Sehgal I; Yang G; Timme TL; Hall SJ; Woo SL; Thompson TC
Hum Gene Ther; 1996 Mar; 7(4):515-23. PubMed ID: 8800746
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
Guan J; Ma L; Wei L
Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195
[TBL] [Abstract][Full Text] [Related]
19. Microencapsulated ciliary neurotrophic factor: physical properties and biological activities.
Maysinger D; Krieglstein K; Filipovic-Grcic J; Sendtner M; Unsicker K; Richardson P
Exp Neurol; 1996 Apr; 138(2):177-88. PubMed ID: 8620916
[TBL] [Abstract][Full Text] [Related]
20. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
